Rifat A. Atun

Imperial College London

Professor of International Health Management

South Kensington Campus

London , DC SW7 2AZ

United Kingdom

http://www.imperial.ac.uk/people/r.atun

SCHOLARLY PAPERS

7

DOWNLOADS

669

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (7)

1.

Financial Sustainability, Accounting and Society

Number of pages: 33 Posted: 03 May 2011 Last Revised: 22 Jan 2015
Nottingham Trent University, London School of Hygiene and Tropical Medicine, Imperial College London and affiliation not provided to SSRN
Downloads 392 (75,162)

Abstract:

Loading...

Financial sustainability, health care trust, under funding practices

2.

National Drug Stockout Risks in Africa: Analysis of the Global Fund Disbursement Process for Procurement from 2002 to 2013​

Ross School of Business Paper No. 1241
Number of pages: 31 Posted: 24 Jun 2014
London Business School, London Business School, Imperial College London and Harvard Medical School
Downloads 115 (242,520)
Citation 1

Abstract:

Loading...

Global Health, Health Financing & Procurement, Global Fund, Drug Stockouts, Africa

3.

Maternal and Child Health in Turkey Through the Health Transformation Program (2003-2008)

Development Analytics Research Paper Series No. 1501
Number of pages: 23 Posted: 12 Dec 2015
Development Analytics, Development Analytics, London School of Hygiene and Tropical Medicine - Department of Public Health and Policy and Imperial College London
Downloads 114 (243,989)
Citation 1

Abstract:

Loading...

Health Insurance, Maternal and Child Health Outcomes, Health Utilization, Social Protection, Green Card, Turkey

4.

Preface to Innovation in the Biopharmaceutical Industry

INNOVATION IN THE BIOPHARMACEUTICAL INDUSTRY, Rifat A. Atun, Desmond Sheridan, eds., World Scientific Publishing, 2007
Number of pages: 1 Posted: 22 Apr 2010
Rifat A. Atun and Desmond Sheridan
Imperial College London and Imperial College London
Downloads 48 (398,534)

Abstract:

Loading...

Pharmaceutical Innovations, Healthcare, Health Systems, Cardiovascular Medicine, Life Sciences, Cancer Medicine, Biopharmaceuticals Sector, Patents, Economic Growth

5.

Innovative Financing for Health: What is Truly Innovative?

Atun R, Knaul FM, Akachi Y, Frenk J. Innovative Financing for Health: What is Truly Innovative? Lancet 2012; 380(9858): 2044-49.
Posted: 31 Jan 2013
Rifat A. Atun, Felicia Knaul, Yoko Akachi and Julio Frenk
Imperial College London, Mexican Health Foundation, Independent and Bill and Melinda Gates Foundation

Abstract:

Loading...

health, innovative finance, low-income and middle-income countries, health systems

6.

Closing the Cancer Divide: An Equity Imperative

Knaul FM, Gralow JR, Atun R, Bhadelia A. (Eds.) based on the work of the Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries. Closing the Cancer Divide: An Equity Imperative. Cambridge, MA: Harvard Global Equity Initiative, 2012. Distributed by Harvard University
Posted: 31 Jan 2013
Mexican Health Foundation, Independent, Imperial College London and Independent

Abstract:

Loading...

cancer, health systems, low-and middle-income countries, impoverishment

7.

Analysis of 'Process Delays' in Care Pathways: Cost Estimation of Waiting Times for Patients With Fractured Neck of Femur (FNOF) in Acute Hospital Setting

iHEA 2007 6th World Congress: Explorations in Health Economics Paper
Posted: 25 Jun 2007
Centre for Health Management, Centre for Health Management, Centre for Health Management and Imperial College London

Abstract:

Loading...

integrated care pathways, hospital efficiency, economic evaluation